lunes, 12 de noviembre de 2018

Pricey precision medicine often financially toxic for cancer patients - STAT

Pricey precision medicine often financially toxic for cancer patients - STAT

Cancer Briefing

Pricey precision medicine often financially toxic for cancer patients

By LIZ SZABO — KAISER HEALTH NEWS


KRISTINA BARKER FOR KHN
Precision medicine — one of the most celebrated areas in cancer research — comes at a high cost, keeping it out of reach for many patients.

No hay comentarios: